Owens & Minor Inc (OMI)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Owens & Minor Inc (OMI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8012251
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月14日
◆ページ数:43
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Owens & Minor Inc (Owens & Minor) is a healthcare services company, which provides supply chain services to healthcare providers and manufacturers of healthcare products. It provides logistics services for disposable medical supplies, devices and implants. Owens & Minor offers medical and surgical products related to admission, anesthesia, diagnostics and equipment, maternity and nursery, O.R. products, patient care, respiratory, and urology. It also offers distribution services and supply-chain management services to healthcare providers and suppliers of medical and surgical products. The company offers its products and services to independent hospitals, large integrated healthcare networks, group purchasing organizations, healthcare products’ manufacturers, and the federal government. It has operations in North America and Europe. Owens & Minor is headquartered in Richmond, Virginia, the US.

Owens & Minor Inc (OMI) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Owens & Minor Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Owens & Minor Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Owens & Minor Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Owens & Minor Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Owens & Minor Inc, Medical Devices Deals, 2011 to YTD 2017 9
Owens & Minor Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Owens & Minor Inc, Pharmaceuticals & Healthcare, Deal Details 11
Debt Offering 11
Owens & Minor Completes Public Offering of 3.875% Notes Due 2021 for USD275 Million 11
Owens & Minor Completes Public Offering of 4.375% Notes Due 2024 for USD275 Million 13
Acquisition 15
Owens & Minor to Acquire Byram Healthcare 15
Owens & Minor Completes Acquisition Of Movianto From Celesio For US$158 Million 17
Owens & Minor Inc – Key Competitors 18
Owens & Minor Inc – Key Employees 19
Owens & Minor Inc – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 23
Financial Announcements 23
Nov 01, 2017: Owens & Minor Reports 3rd Quarter 2017 Financial Results 23
Aug 01, 2017: Owens & Minor Reports 2nd Quarter 2017 Financial Results 25
May 02, 2017: Owens & Minor Reports 1st Quarter 2017 Financial Results 27
Mar 16, 2017: Owens & Minor Outlined its New Strategic Plan and Reaffirmed its Financial Outlook for 2017 and 2018 at Annual Investor Meeting 28
Feb 14, 2017: Owens & Minor Reports 4th Quarter & Full-Year 2016 Financial Results 29
Nov 01, 2016: Owens & Minor Releases 3rd Quarter 2016 Financial Results 31
Aug 02, 2016: Owens & Minor Reports 2nd Quarter 2016 Financial Results 33
May 03, 2016: Owens & Minor Reports 1st Quarter 2016 Financial Results 35
Feb 08, 2016: Owens & Minor Reports 4th Quarter & Full-Year 2015 Financial Results 37
Corporate Communications 39
Mar 13, 2017: Owens & Minor Welcomes New EVP of Global Manufacturer Services 39
Feb 10, 2017: Owens & Minor Announces That Healthcare Executive Barbara B. Hill Has Been Elected to Its Board of Directors 40
Feb 10, 2017: Craig R. Smith, Chairman of the Owens & Minor Board of Directors, Announces His Retirement 41
Other Significant Developments 42
Oct 23, 2017: Healthier Communities 20/20: A Clear Vision for Our Future; Owens & Minor will Explore this Theme at its 12th Annual Healthcare Supplier Diversity Symposium 42
Appendix 43
Methodology 43
About GlobalData 43
Contact Us 43
Disclaimer 43

List of Tables
Owens & Minor Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Owens & Minor Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Owens & Minor Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Owens & Minor Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Owens & Minor Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Owens & Minor Inc, Medical Devices Deals, 2011 to YTD 2017 9
Owens & Minor Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Owens & Minor Completes Public Offering of 3.875% Notes Due 2021 for USD275 Million 11
Owens & Minor Completes Public Offering of 4.375% Notes Due 2024 for USD275 Million 13
Owens & Minor to Acquire Byram Healthcare 15
Owens & Minor Completes Acquisition Of Movianto From Celesio For US$158 Million 17
Owens & Minor Inc, Key Competitors 18
Owens & Minor Inc, Key Employees 19
Owens & Minor Inc, Other Locations 20
Owens & Minor Inc, Subsidiaries 21

★海外企業調査レポート[Owens & Minor Inc (OMI)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • TTEC Holdings Inc.:企業の戦略・SWOT・財務情報
    TTEC Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary TTEC Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Currence Holding B.V.:企業の戦略・SWOT・財務情報
    Currence Holding B.V. - Strategy, SWOT and Corporate Finance Report Summary Currence Holding B.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Wentworth Resources Ltd (WRL):石油・ガス:M&Aディール及び事業提携情報
    Summary Wentworth Resources Ltd (Wentworth) is an independent upstream oil and gas company. It conducts the exploration and development of oil and natural gas reserves. The company has producing gas assets in Tanzania, oil and gas exploration activities in both Mozambique and Tanzania. The company o …
  • UNIQA Biztosito Zrt.:企業の戦略・SWOT・財務情報
    UNIQA Biztosito Zrt. - Strategy, SWOT and Corporate Finance Report Summary UNIQA Biztosito Zrt. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Prognomix Inc:企業の製品パイプライン分析
    Summary Prognomix Inc (Prognomix) is a personalized medicine company that develops molecular diagnostic test for detection of risks to develop renal, ocular, cardiac, cerebral, vascular and other complications of diabetic disease. The company’s products include PGX IR01, PGx GR01, PGx CD01, PGx IR02 …
  • XOMA Corp (XOMA):企業の財務・戦略的SWOT分析
    XOMA Corp (XOMA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Extendicare Inc (EXE):企業の財務・戦略的SWOT分析
    Summary Extendicare Inc (Extendicare), formerly Crownx Inc is a healthcare service provider that offers long-term care services. The center’s services include short stay care, convalescent care, home health care, group purchasing, assisted living, retirement living, workplace health and wellness, sk …
  • Gardiner & Theobald LLP:企業の戦略的SWOT分析
    Gardiner & Theobald LLP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Aben Resources Ltd (ABN):企業の財務・戦略的SWOT分析
    Summary Aben Resources Ltd (Aben Resources) is a mining and mineral exploration and development company. The company offers o acquisition, exploration, operations, mining, management production, and development of lithium, uranium, gold, lead, silver, zinc, copper, and mineral resource deposit prope …
  • Seiko Epson Corporation:企業の戦略・SWOT・財務情報
    Seiko Epson Corporation - Strategy, SWOT and Corporate Finance Report Summary Seiko Epson Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • AmpliPhi Biosciences Corp (APHB):製薬・医療:M&Aディール及び事業提携情報
    Summary AmpliPhi Biosciences Corp (AmpliPhi) is a biotechnology company which focuses on development and commercialization of bacteriophage-based antibacterial therapeutics. The company by utilizing its proprietary bacteriophage technology developed a pipeline of products for the treatment of variou …
  • Otto Energy Ltd (OEL):石油・ガス:M&Aディール及び事業提携情報
    Summary Otto Energy Ltd (Otto Energy), formerly Ottoman Energy Ltd, is an oil and gas company that offers exploration, production, and development of oil and gas properties. The company's products include oil and gas. It operates its exploration properties located in the Offshore Gulf of Mexico such …
  • Crown Point Energy Inc (CWV):石油・ガス:M&Aディール及び事業提携情報
    Summary Crown Point Energy Inc (Crown Point), formerly Crown Point Ventures is an oil and gas company that offers oil and gas development and exploration services. The company acquires and produces crude oil and natural gas deposits. It holds interests in Cerro de Los Leones exploration concessions …
  • Reliance Communications Ltd (RCOM):企業の財務・戦略的SWOT分析
    Reliance Communications Ltd (RCOM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • GAIL (India) Limited:企業の戦略・SWOT・財務分析
    GAIL (India) Limited - Strategy, SWOT and Corporate Finance Report Summary GAIL (India) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Gulf Investment Corp:企業の戦略的SWOT分析
    Gulf Investment Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Bank of Communications Ltd (601328):企業の財務・戦略的SWOT分析
    Bank of Communications Ltd (601328) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Varian Medical Systems, Inc.:戦略・SWOT・企業財務分析
    Varian Medical Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary Varian Medical Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • London Stock Exchange Group Plc:戦略・SWOT・企業財務分析
    London Stock Exchange Group Plc - Strategy, SWOT and Corporate Finance Report Summary London Stock Exchange Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Norwegian Energy Company ASA:企業のM&A・事業提携・投資動向
    Norwegian Energy Company ASA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Norwegian Energy Company ASA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆